Table II.
Overall survival | Disease-free survival | |||||
---|---|---|---|---|---|---|
Characteristic | HR | 95% CI | P-Value | HR | 95% CI | P-value |
Age (≥60 vs. <60 years) | 1.129 | 0.613–2.077 | 0.697 | 1.157 | 0.628–2.130 | 0.641 |
Gender (female vs. male) | 0.863 | 0.423–1.763 | 0.686 | 0.908 | 0.445–1.855 | 0.792 |
Position (upper vs. middle vs. lower) | 1.329 | 0.690–2.560 | 0.396 | 1.319 | 0.686–2.538 | 0.406 |
Differentiation (high vs. moderate vs. poor) | 1.254 | 0.796–1.974 | 0.329 | 1.252 | 0.795–1.971 | 0.332 |
TNM stage (I vs. II vs. III) | 3.379 | 1.919–5.952 | <0.001a | 3.497 | 1.979–6.181 | <0.001a |
P53 expression (low vs. high) | 2.102 | 1.108–3.991 | 0.023a | 2.138 | 1.127–4.056 | 0.020a |
Cox-2 expression (low vs. high) | 1.473 | 0.742–2.923 | 0.268 | 1.453 | 0.734–2.875 | 0.283 |
P53(+) Cox-2(+) vs. other groups | 2.212 | 1.219–4.012 | 0.009a | 2.221 | 1.228–4.017 | 0.008a |
P<0.05. HR, hazard ratio; CI, confidence interval.